Farmer ER, Gonin R, Hanna MP. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum. Pathol. 27(6), 528-531 (1996).
Grant-Kels JM, Bason ET, Grin CM. The misdiagnosis of malignant melanoma. J. Am. Acad. Dermatol. 40(4), 539-548 (1999).
Brochez L, Verhaeghe E, Grosshans E et al. Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions. J. Pathol. 196(4), 459-466 (2002).
Quatresooz P, Piérard-Franchimont C, Piérard GE. Highlighting the immunohistochemical profile of melanocytomas: review. Oncol. Rep. 19(6), 1367-1372 (2008).
Darier J, Civatte A. Naevus ou naevocarcinoma chez un nourisson. Bull. Soc. Franc. Derm. Syph. 21, 61-63 (1910).
Spitz S. Melanomas of childhood. Am. J. Pathol. 24(3), 591-609 (1948).
Spitz S. Cutaneous tumors of childhood. Disparity between clinical behavior and histologic appearance. J. Am. Med. Womens Assoc. 6(6), 209-219 (1951).
Orchard DC, Dowling JP, Kelly JW. Spitz naevi misdiagnosed histologically as melanoma: prevalence and clinical profile. Australas. J. Dermatol. 38(1), 12-14 (1997).
Walsh N, Crotty K, Palmer A, McCarthy S. Spitz nevus versus Spitzoid malignant melanoma: an evaluation of the current distinguishing histopathologic criteria. Hum. Pathol. 29(10), 1105-1112 (1998).
Barnhill RL, Argenyi ZB, From L et al. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum. Pathol. 30(5), 513-520 (1999).
Spatz A, Calonje E, Handfield-Jones S, Barnhill RL. Spitz tumors in children: a grading system for risk stratification. Arch. Dermatol. 135(3), 282-285 (1999).
Gurbuz Y, Apaydin R, Muezzinoglu B, Buyukbabani N. A current dilemma in histopathology: atypical Spitz tumor or Spitzoid melanoma? Pediatr. Dermatol. 19(2), 99-102 (2002).
Mones JM, Ackerman AB. 'Atypical' Spitz's nevus, 'malignant' Spitz's nevus, and 'metastasizing' Spitz's nevus: a critique in historical perspective of three concepts flawed fatally. Am. J. Dermatopathol. 26(4), 310-333 (2004).
Lee JB. Spitz nevus versus melanoma: limitation of the diagnostic methodology exposed. Eur. J. Dermatol. 16(3), 223-224 (2006).
Mooi WJ, Krausz T. Spitz nevus versus Spitzoid melanoma: diagnostic difficulties, conceptual controversies. Adv. Anat. Pathol. 13(4), 147-156 (2006).
Sepehr A, Chao E, Trefrey B et al. Long-Term outcome of Spitz-Type melanocytic tumors. Arch. Dermatol. 147(10), 1173-1179 (2011).
Bourguignon JP, Piérard GE, Ernould C et al. Effects of human growth hormone therapy on melanocytic naevi. Lancet 341(8859), 1505-1506 (1993).
Ball NJ, Golitz LE. Melanocytic nevi with focal atypical epithelioid cell components: a review of seventy-Three cases. J. Am. Acad. Dermatol. 30(5 Pt 1), 724-729 (1994).
Paquet P, Arrese JE, Greimers R et al. Eruptive speckled melanocytic nevi following drug-induced toxic epidermal necrolysis. Eur. J. Dermatol. 5, 379-382 (1995).
Piérard GE, Piérard-Franchimont C, Nikkels A, Nikkels-Tassoudji N, Arrese JE, Bourguignon JP. Naevocyte triggering by recombinant human growth hormone. J. Pathol. 180(1), 74-79 (1996).
Sabroe RA, Vaingankar NV, Rigby HS, Peachey RD. Agminate Spitz naevi occurring in an adult after the excision of a solitary Spitz naevus-report of a case and review of the literature. Clin. Exp. Dermatol. 21(3), 197-200 (1996).
Collina G, Deen S, Cliff S, Jackson P, Cook MG. Atypical dermal nodules in benign melanocytic naevi. Histopathology 31(1), 97-101 (1997).
Onsun N, Saraçoglu S, Demirkesen C, Kural YB, Atilganoglu U. Eruptive widespread Spitz nevi: can pregnancy be a stimulating factor? J. Am. Acad. Dermatol. 40(5 Pt 2), 866-867 (1999).
Reginster MA, Pierard-Franchimont C, Piérard GE, Quatresooz P. Molecular dermatopathology in malignant melanoma. Dermatol. Res. Pract. 2012, 684032 (2012).
Piérard GE, Piérard-Franchimont C, Delvenne P. Streamlining molecular pathobiology of malignant melanoma. In: Essentials of Diagnostic Pathology/Molecular Pathology. Hoefler G, van Krieken H, Hummel M, Stanta G (Eds). Springer Verlag, Berlin, Heidelberg, Germany (In Press).
Turhan T, Oner K, Yurtseven T, Akalin T, Ovul I. Spinal meningeal melanocytoma. Report of two cases and review of the literature. J. Neurosurg. 100(3 Suppl. Spine), 287-290 (2004).
O'Brien DF, Crooks D, Mallucci C et al. Meningeal melanocytoma. Childs. Nerv. Syst. 22(6), 556-561 (2006).
Park SI, Cho KO. Dermal melanocytomaacanthoma in an adult mixed breed dog. Jpn J. Vet. Res. 58(3-4), 165-169 (2010).
Liu W, Bennett M, Helm T. Canine melanoma: a comparison with human pigmented epithelioid melanocytoma. Int. J. Dermatol. 50(12), 1542-1545 (2011).
Semin MO, Serra F, Mahe V, Deviers A, Regnier A, Raymond-Letron I. Choroidal melanocytoma in a cat. Vet. Ophthalmol. 14(3), 205-208 (2011).
Ainsworth AM, Folberg R, Reed RJ, Clark W. Melanocytic nevi, melanocytomas, melanocytic dysplasias, and uncommon forms of melanoma. In: Human Malignant Melanoma, Clinical Oncology Monographs. Clark WH, Goldman KI, Mastrangelo MJ (Eds). Grune & Stratton, New York, NY, USA, 167-208 (1979).
Fraitag S, Vignon-Pennamen MD. Spitz tumor and pigmented epithelioid melanocytoma: new nosological frameworks for commonly ill-defined tumors. Ann. Dermatol. Venereol. 136(2), 133-144 (2009).
Mandal RV, Murali R, Lundquist KF et al. Pigmented epithelioid melanocytoma: favorable outcome after 5-year follow-up. Am. J. Surg. Pathol. 33(12), 1778-1782 (2009).
Quatresooz P, Arrese JE, Pierard-Franchimont C, Pierard GE. Immunohistochemical aid at risk stratification of melanocytic neoplasms. Int. J. Oncol. 24(1), 211-216 (2004).
Piérard GE, Al Rustom K. Dysplastic nevi and the concept of triggered melanocytic system. Em. Med. J. 7, 3-6 (1989).
Aktürk AS, Bilen N, Bayrämgürler D, Demirsoy EO, Erdogan S, Kiran R. Dermoscopy is a suitable method for the observation of the pregnancy-related changes in melanocytic nevi. J. Eur. Acad. Dermatol. Venereol. 21(8), 1086-1090 (2007).
Tronnier M, Wolff HH. UV-irradiated melanocytic nevi simulating melanoma in situ. Am. J. Dermatopathol. 17(1), 1-6 (1995).
Brozyna A, Zbytek B, Granese J, Carlson JA, Ross J, Slominski A. Mechanism of UV-related carcinogenesis and its contribution to nevi/melanoma. Expert Rev. Dermatol. 2(4), 451-469 (2007).
Raimondi S, Sera F, Gandini S et al. MC1R variants, melanoma and red hair color phenotype: a meta-Analysis. Int. J. Cancer 122(12), 2753-2760 (2008).
Gandini S, Sera F, Cattaruzza MS et al. Meta-Analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur. J. Cancer 41(1), 45-60 (2005).
Bataille V, Boniol M, De Vries E et al. A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. Eur. J. Cancer 41(14), 2141-2149 (2005).
Gandini S, Sera F, Cattaruzza MS et al. Meta-Analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur. J. Cancer 41(1), 28-44 (2005).
Falchi M, Spector TD, Perks U, Kato BS, Bataille V. Genome-wide search for nevus density shows linkage to two melanoma loci on chromosome 9 and identifies a new QTL on 5q31 in an adult twin cohort. Hum. Mol. Genet. 15(20), 2975-2979 (2006).
Zhu G, Montgomery GW, James MR et al. A genome-wide scan for naevus count: linkage to CDKN2A and to other chromosome regions. Eur. J. Hum. Genet. 15(1), 94-102 (2007).
Chang YM, Newton-Bishop JA, Bishop DT et al. A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes. Int. J. Cancer 124(2), 420-428 (2009).
Pérez-Gómez B, Aragonés N, Gustavsson P, Lope V, López-Abente G, Pollán M. Do sex and site matter? Different age distribution in melanoma of the trunk among Swedish men and women. Br. J. Dermatol. 158(4), 766-772 (2008).
Uhoda I, Quatresooz P, Fumal I, Nikkels AF, Piérard-Franchimont C, Piérard GE. Updating trends in cutaneous cancers in south-east Belgium. Oncol. Rep. 12(1), 111-114 (2004).
Zembowicz A, Carney JA, Mihm MC. Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-Type melanoma and epithelioid blue nevus. Am. J. Surg. Pathol. 28(1), 31-40 (2004).
Antony FC, Sanclemente G, Shaikh H, Trelles AS, Calonje E. Pigment synthesizing melanoma (so-called animal type melanoma): a clinicopathological study of 14 cases of a poorly known distinctive variant of melanoma. Histopathology 48(6), 754-762 (2006).
Ludgate MW, Fullen DR, Lee J et al. Animal-Type melanoma: a clinical and histopathological study of 22 cases from a single institution. Br. J. Dermatol. 162(1), 129-136 (2010).
Quatresooz P, Pierard-Franchimont C, Pierard GE; Mosan Study Group Of Pigmented Tumors. Molecular histology on the diagnostic cutting edge between malignant melanomas and cutaneous melanocytomas (Review). Oncol. Rep. 22(6), 1263-1267 (2009).
Alonso SR, Ortiz P, Pollán M et al. Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarraybased study. Am. J. Pathol. 164(1), 193-203 (2004).
Bergman R, Dromi R, Trau H, Cohen I, Lichtig C. The pattern of HMB-45 antibody staining in compound Spitz nevi. Am. J. Dermatopathol. 17(6), 542-546 (1995).
Kanter-Lewensohn L, Hedblad MA, Wejde J, Larsson O. Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas. Mod. Pathol. 10(9), 917-920 (1997).
Kapur P, Selim MA, Roy LC, Yegappan M, Weinberg AG, Hoang MP. Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis. Mod. Pathol. 18(2), 197-204 (2005).
Orlandi A, Costantini S, Campione E et al. Relation between animal-Type melanoma and reduced nuclear expression of glutathione S-Transferase pi. Arch. Dermatol. 145(1), 55-62 (2009).
Paquet P, Piérard GE. Glutathione-S-Transferase pi expression in toxic epidermal necrolysis: a marker of putative oxidative stress in keratinocytes. Skin Pharmacol. Physiol. 20(2), 66-70 (2007).
Quatresooz P, Piérard GE. Immunohistochemical investigation of α1 (IV) and α5 (IV) collagen chains in a broad spectrum of melanocytic tumours. Melanoma Res. 15(3), 161-168 (2005).
Piérard GE, Piérard-Franchimont C. HOX gene aberrant expression in skin melanoma. J. Skin Cancer 2012, 707260 (2012).
Abásolo A, Vargas MT, Ríos-Martín JJ, Trigo I, Arjona A, González-Cámpora R. Application of fluorescence in situ hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax-embedded tissues and imprint-cytology specimens. Clin. Exp. Dermatol. 37(8), 838-843 (2012).
de Klein A, Koopmans AE, Kilic E. Multicolor FISH with improved sensitivity and specificity in the diagnosis of malignant melanoma. Expert Rev. Mol. Diagn. 12(7), 683-685 (2012).
Gammon B, Gerami P. Fluorescence in situ hybridization for ambiguous melanocytic tumors. Histol. Histopathol. 27(12), 1539-1542 (2012).
Kiuru M, Patel RM, Busam KJ. Desmoplastic melanocytic nevi with lymphocytic aggregates. J. Cutan. Pathol. 39(10), 940-944 (2012).
Pennacchia I, Garcovich S, Gasbarra R, Leone A, Arena V, Massi G. Morphological and molecular characteristics of nested melanoma of the elderly (evolved lentiginous melanoma). Virchows Arch. 461(4), 433-439 (2012).
Requena C, Rubio L, Traves V et al. Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and Spitzoid melanoma. Histopathology 61(5), 899-909 (2012).
Ali L, Helm T, Cheney R et al. Correlating array comparative genomic hybridization findings with histology and outcome in Spitzoid melanocytic neoplasms. Int. J. Clin. Exp. Pathol. 3(6), 593-599 (2010).
Gerami P, Pouryazdanparast P, Vemula S, Bastian BC. Molecular analysis of a case of nevus of ota showing progressive evolution to melanoma with intermediate stages resembling cellular blue nevus. Am. J. Dermatopathol. 32(3), 301-305 (2010).
Vanison C, Tanna N, Murthy AS. Comparative genomic hybridization for the diagnosis of melanoma. Eur. J. Plast. Surg. 33(1), 45-48 (2010).
de la Fouchardière A, Vergier B. Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH). Ann. Pathol. 31, S115-S116 (2011).
Abraham RM, Ming ME, Elder DE, Xu X. An atypical melanocytic lesion without genomic abnormalities shows locoregional metastasis. J. Cutan. Pathol. 39(1), 21-24 (2012).
Held L, Metzler G, Eigentler TK et al. Recurrent nodules in a periauricular plaque-Type blue nevus with fatal outcome. J. Cutan. Pathol. 39(12), 1088-1093 (2012).
Yeh I, Vemula SS, Mirza SA, McCalmont TH. Neurofibroma-like spindle cell melanoma: CD34 fingerprint and CGH for diagnosis. Am. J. Dermatopathol. 34(6), 668-670 (2012).
Lohmann CM, Coit DG, Brady MS, Berwick M, Busam KJ. Sentinel lymph node biopsy in patients with diagnostically controversial Spitzoid melanocytic tumors. Am. J. Surg. Pathol. 26(1), 47-55 (2002).
Pierard GE, Pierard-Franchimont C. The proliferative activity of cells of malignant melanomas. Am. J. Dermatopathol. 6, 317-323 (1984).
Piérard GE, Piérard-Franchimont C. Stochastic relationship between the growth fraction and vascularity of thin malignant melanomas. Eur. J. Cancer 33(11), 1888-1892 (1997).
Banerjee SS, Harris M. Morphological and immunophenotypic variations in malignant melanoma. Histopathology 36(5), 387-402 (2000).
Li LX, Crotty KA, McCarthy SW, Palmer AA, Kril JJ. A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions. Am. J. Dermatopathol. 22(6), 489-495 (2000).
Bergman R, Malkin L, Sabo E, Kerner H. MIB-1 monoclonal antibody to determine proliferative activity of Ki-67 antigen as an adjunct to the histopathologic differential diagnosis of Spitz nevi. J. Am. Acad. Dermatol. 44(3), 500-504 (2001).
Fecher LA, Cummings SD, Keefe MJ, Alani RM. Toward a molecular classification of melanoma. J. Clin. Oncol. 25(12), 1606-1620 (2007).
Ohsie SJ, Sarantopoulos GP, Cochran AJ, Binder SW. Immunohistochemical characteristics of melanoma. J. Cutan. Pathol. 35(5), 433-444 (2008).
Quatresooz P, Pierard GE, Pierard-Franchimont C; Mosan Study Group of Pigmented Tumors. Molecular pathways supporting the proliferation staging of malignant melanoma (review). Int. J. Mol. Med. 24(3), 295-301 (2009).
Quatresooz P, Pierard-Franchimont C, Paquet P, Pierard GE. Angiogenic fast-growing melanomas and their micrometastases. Eur. J. Dermatol. 20(3), 302-307 (2010).
Gaudi S, Messina JL. Molecular bases of cutaneous and uveal melanomas. Patholog. Res. Int. doi:10.4061/2011/159421 (2011) (Epub ahead of print).
Quatresooz P, Piérard GE. Malignant melanoma: from cell kinetics to micrometastases. Am. J. Clin. Dermatol. 12(2), 77-86 (2011).
Piérard GE. Cell proliferation in malignant melanoma: relationship with neoplastic progression. Int. Schol. Res. Network Dermatol. doi:10.5402/2012/828146 (2012) (Epub ahead of print).
Richmond-Sinclair NM, Lee E, Cummings MC et al. Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53, and p16 immunostaining in cutaneous melanomas. Melanoma Res. 18(5), 336-345 (2008).
Piérard GE, Piérard-Franchimont C, Hermanns-Lê T, Delvenne P. Cutaneous malignant melanoma: one single disease? Rev. Med. Liege. 67(9), 458-460 (2012).
Piérard GE, Piérard-Franchimont C, Reginster MA, Quatresooz P. Smouldering malignant melanoma and metastatic dormancy. An update and review. Derm. Res. Prac. 2012, 461278 (2012).
Piérard GE, Piérard-Franchimont C, Delvenne P. Malignant melanoma and its stromal nonimmune microecosystem. J. Oncol. doi:10.1155/2012/584219 (2012) (Epub ahead of print).
Mangini J, Li N, Bhawan J. Immunohistochemical markers of melanocytic lesions: a review of their diagnostic usefulness. Am. J. Dermatopathol. 24(3), 270-281 (2002).
Hussein MR, Haemel AK, Wood GS. Apoptosis and melanoma: molecular mechanisms. J. Pathol. 199(3), 275-288 (2003).
Vollmer RT. Use of Bayes rule and MIB-1 proliferation index to discriminate Spitz nevus from malignant melanoma. Am. J. Clin. Pathol. 122(4), 499-505 (2004).
Heymans O, Blacher S, Brouers F, Piérard GE. Fractal quantification of the microvasculature heterogeneity in cutaneous melanoma. Dermatology (Basel) 198(2), 212-217 (1999).
Quatresooz P, Piérard GE, Piérard-Franchimont C, Humbert P, Piérard S. Spectral analysis of the microvasculature of primary cutaneous melanoma. Pathol. Biol. 60(2), 149-153 (2012).
Bayer-Garner IB, Hough AJ Jr, Smoller BR. Vascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness. Mod. Pathol. 12(8), 770-774 (1999).
Cockerell CJ, Sonnier G, Kelly L, Patel S. Comparative analysis of neovascularization in primary cutaneous melanoma and Spitz nevus. Am. J. Dermatopathol. 16(1), 9-13 (1994).
Piérard-Franchimont C, Henry F, Heymans O, Piérard GE. Vascular retardation in dormant growth-stunted malignant melanomas. Int. J. Mol. Med. 4(4), 403-406 (1999).
Diaz-Cascajo C, Borghi S, Weyers W. Angiomatoid Spitz nevus: a distinct variant of desmoplastic Spitz nevus with prominent vasculature. Am. J. Dermatopathol. 22(2), 135-139 (2000).
